Evidence map›Paper›PMID 26258781›Full record

ArticleMarine drugs2015

Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential.

Henrik Harms, Barbora Orlikova, Seungwon Ji, Damun Nesaei-Mosaferan, Gabriele M König, Marc Diederich

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Studies in mycology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Henrik HarmsInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, Bonn D-53115, Germany. henrik-harms@gmx.de.
Barbora OrlikovaDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. barbora.orlikova@lbmcc.lu.
Seungwon JiDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. jsw0525@snu.ac.kr.
Damun Nesaei-MosaferanInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, Bonn D-53115, Germany. damun1363@hotmail.de.
Gabriele M KönigInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, Bonn D-53115, Germany. g.koenig@uni-bonn.de.
Marc DiederichDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. marcdiederich@snu.ac.kr.
Seoul National University · KRUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ascomycota Dichotomomyces cejpii was isolated from the marine sponge Callyspongia cf. C. flammea. A new gliotoxin derivative, 6-acetylmonodethiogliotoxin (1) was obtained from fungal extracts. Compounds 2 and 3, methylthio-gliotoxin derivatives were formerly only known as semi-synthetic compounds and are here described as natural products. Additionally the polyketide heveadride (4) was isolated. Compounds 1, 2 and 4 dose-dependently down-regulated TNFα-induced NF-κB activity in human chronic myeloid leukemia cells with IC50s of 38.5 ± 1.2 µM, 65.7 ± 2.0 µM and 82.7 ± 11.3 µM, respectively. The molecular mechanism was studied with the most potent compound 1 and results indicate downstream inhibitory effects targeting binding of NF-κB to DNA. Compound 1 thus demonstrates potential of epimonothiodiketopiperazine-derived compounds for the development of NF-κB inhibitors.

Indexed as

AnimalsAquatic OrganismsAscomycotaBiological ProductsCallyspongiaCell Line, TumorDNAFungiGliotoxinHumansJurkat CellsK562 CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNF-kappa BPiperazinesPolyketidesBiological ProductsDNAepipolythiodiketopiperazineGliotoxinNF-kappa BPiperazinesPolyketidesAscomyceteDichotomomycesgliotoxinleukemiaNF-κB

Identifiers

PMID26258781
PMCPMC4557009
OpenAlexW1786181488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.